China Universal Asset Management »

Oric Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $178k 13k 13.78
2023-12-31 $58k 6.3k 9.20
2022-09-30 $999 370 2.70

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
Column Group
EcoR1 Capital
VR Adviser
Vanguard Group
Frazier Life Sciences Management
Arrowpoint Asset Management
Boxer Capital
Invus Financial Advisors
Euclidean Capital
Vivo Capital
Franklin Resources
Henderson Group
T. Rowe Price Associates
OrbiMed Advisors

View all funds holding Oric Pharmaceuticals